![Jonathan Aballi, President and Chief Executive Officer. [NASDAQ XGN] at Exagen](https://exagen.wpenginepowered.com/wp-content/uploads/2022/11/John-A-Headshot.png){kind=small}
Sera Prognostics
Manufacturing · Utah, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
2749 E Parleys Way Ste 200, Salt Lake Ci...Phone Number
(801) 990-0520Website
www.seraprognostics.comRevenue
<$5 MillionStock Symbol
SERAIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
2
1
1
1
1
About Sera Prognostics
Sera Prognostics was founded to develop diagnostic tests for the early prediction of a womans individualized risk of premature birth, preeclampsia, and other pregnancy complications. Seras tests are designed to give women and their physicians the power and time to make a difference in maternal and newborn health with individualized treatment and care plans.Explore more
Popular SearchesSera Prognostics IncSera PrognosticsSIC Code 38,382NAICS Code 33,334Ticker NASDAQ: SERAShow moreSera Prognostics Org Chart
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Sera Prognostics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Congratulate Masked Content for being promoted to Masked Content at Sera Prognostics
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if Sera Prognostics is spiking on competitors!
Check if Sera Prognostics has recently received funding, and reach out quickly before it becomes old news!
Earning: See what the market has to say on Sera Prognostics recently announced quarterly report
Product Launch: Get notified when Sera Prognostics launches new products
Sera Prognostics, which may be a good buyer, showed buying intent in Masked Content Topic
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Sera Prognostics has new funding data
Click to see if Sera Prognostics had a recent Job posting/layoffs
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Sera Prognostics
Compare insights from companies similar to Sera Prognostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Company Profile Activity
Activity Insights
Sera Prognostics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Sera Prognostics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Sera Prognostics.
Sera Prognostics financials insights
Gather financial insights about Sera Prognostics, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2013
Debt
$4.5M
2014
Private Equity
$9.2M
Private Equity
$5M
2015
Series B
$25M
Debt
$10M
2017
Series C
$40M
2019
Series D
$36M
2020
Debt
$1M
2021
Series E
$100M
Share Placement
$75M
Sera Prognostics Tech Stack
A closer look at the technologies used by Sera Prognostics
See more technologies
Most Recent Scoops
Person-Based
Earnings, Finance
Person-Based
Financial Planning, Business Finance, Corporate Strategy, Finance
Person-Based
Advertising, Branding, Communications, Marketing Communications
Project
, according to a mid-level source in diversity & inclusion, is in the midst of initiatives related to workforce planning and optimization. The organization is currently evaluating ADP Workforce Now.
Employee Relations, Workforce Management, Company Culture & Policy, Diversity & Inclusion, HR Operations, Organizational Development
Project
Employee Relations, Company Culture & Policy, Diversity & Inclusion, HR Operations
Sera Prognostics News & Media
SERA APPLAUDS ILLINOIS INITIATIVE TO EXPAND MEDICAID COVERAGE FOR PROTEOMIC BLOOD TESTING IN PREGNANCY
--Aligns With Growing Focus on Early Identification and Management of Preterm Birth Risk-- SALT LAKE CITY, June 23, 2026 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy...SERA PROGNOSTICS ANNOUNCES BOARD TRANSITION
SALT LAKE CITY, June 1, 2026 /PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (Nasdaq: SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today announced that Jeff Elliott has notified the...Sera Prognostics Q4 Earnings Call Highlights
Sera Prognostics (NASDAQ:SERA) executives emphasized progress in evidence generation and early commercialization efforts during the company’s fourth-quarter and full-year 2025 earnings call, held March 18, 2026. Management highlighted the publication of its pivotal PRIME study, a growing pipeline ofSera Prognostics: Blood test cuts early preterm births, NICU use - Stock Titan
In a 5,018-patient PRIME trial, PreTRM screening cut births before 32 weeks by 56% and NICU admissions by 20%, saving 1 NICU day per 4.2 women tested.
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Sera Prognostics
Sign Up For FreeTo access detailed company insights
Sera Prognostics was founded to develop diagnostic tests for the early prediction of a womans individualized risk of premature birth, preeclampsia, and other pregnancy complications. Seras tests are designed to give women and their physicians the power and time to make a difference in maternal and newborn health with individualized treatment and ca... Read More
